EcoDrugPlus

Ensembl ID : ENSVVUG00000024483
Gene Symbol: -
Cross references: -
237 Possible Orthologues:

Ensembl ID : ENSVVUG00000030363
Gene Symbol: -
Cross references: -
107 Possible Orthologues:

Ensembl ID : ENSVVUG00000026690
Gene Symbol: -
Cross references: -
94 Possible Orthologues:

Ensembl ID : ENSVVUG00000027068
Gene Symbol: -
Cross references: -
139 Possible Orthologues:

Ensembl ID : ENSVVUG00000027618
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Ensembl ID : ENSVVUG00000024243
Gene Symbol: -
Cross references: -
188 Possible Orthologues:

Ensembl ID : ENSVVUG00000023386
Gene Symbol: -
Cross references: -
255 Possible Orthologues:

Ensembl ID : ENSVVUG00000023448
Gene Symbol: -
Cross references: -
142 Possible Orthologues:

Ensembl ID : ENSVVUG00000018445
Gene Symbol: -
Cross references: -
136 Possible Orthologues:

Ensembl ID : ENSVVUG00000010832
Gene Symbol: -
Cross references: -
56 Possible Orthologues:

Ensembl ID : ENSVVUG00000006852
Gene Symbol: -
Cross references: -
63 Possible Orthologues:

Ensembl ID : ENSVVUG00000012920
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).